In October 2017, the FDA approved and ACIP recommended a Shingrix (RZV) vaccine for adults ≥50 years of age. Zostavax (ZVL) is no longer available for use in the United States, as of November 18, 2020.
Shingrix is recommended for the prevention of herpes zoster and related complications for immunocompetent adults aged ≥50 years
Adverse Events
CDC: Shingles (Herpes Zoster) Vaccination Information for Healthcare Providers
FDA: SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
We are pleased to bring you the CDC vaccination schedule, for individuals 19 years of age and older. Click here to see the Birth-18 Years schedule.
Note that on certain mobile devices, you will need to scroll horizontally to see Tables in their entirety. Details on individual disorders and vaccines appear at the bottom of the Tables. Another option is to tap the ‘compliant version’ link. The PDF icons below will also take you to the current schedules and information and can be saved to your device.
We are pleased to bring you the CDC vaccination schedule, from birth to 18 years of age. Click here to see the adult schedule.
Alert: On October 20, 2016, the CDC changed the HPV vaccine recommendation:
CDC press release: CDC recommends only two HPV shots for younger adolescents
Want to hear about the latest clinical summaries via ObG Insider?
Tap Here to get your free e-Newsletter »
Please log in to ObGFirst to access the 2T US Atlas